These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6247159)

  • 21. Behavioral and neurochemical effects of delta 9-tetrahydrocannabinol in rats.
    Bhattacharyya AK; Aulakh CS; Pradhan S; Ghosh P; Pradhan SN
    Neuropharmacology; 1980 Jan; 19(1):87-95. PubMed ID: 6102355
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of vasopressin V1a receptor in ∆
    Egashira N; Koushi E; Myose T; Tanoue A; Mishima K; Tsuchihashi R; Kinjo J; Tanaka H; Morimoto S; Iwasaki K
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3475-3483. PubMed ID: 28905207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative effects of combinations of delta 9-tetrahydrocannabinol and pentobarbital in pigeons.
    Järbe TU; Ohlin GC
    Psychopharmacology (Berl); 1979 Jun; 63(3):233-9. PubMed ID: 113808
    [No Abstract]   [Full Text] [Related]  

  • 24. Some pharmacological effects of phenitrone and its interaction with 9 -THC.
    Spaulding TC; Ford RD; Dewey WL; McMillan DE; Harris LS
    Eur J Pharmacol; 1972 Sep; 19(3):310-7. PubMed ID: 4640854
    [No Abstract]   [Full Text] [Related]  

  • 25. The toxicologic and teratologic effects of delta-9-tetrahydrocannabinol in the zebrafish embryo.
    Thomas RJ
    Toxicol Appl Pharmacol; 1975 Apr; 32(1):184-90. PubMed ID: 1135874
    [No Abstract]   [Full Text] [Related]  

  • 26. The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2.
    Fairbairn JW; Pickens JT
    Br J Pharmacol; 1979 Nov; 67(3):379-85. PubMed ID: 574040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide.
    Pertwee RG; Greentree SG
    Neuropharmacology; 1988 May; 27(5):485-91. PubMed ID: 2839791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
    Smith PB; Martin BR
    Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary experiments on the chemistry and pharmacology of cannabis.
    Gill EW; Paton WD; Pertwee RG
    Nature; 1970 Oct; 228(5267):134-6. PubMed ID: 5466704
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute toxicity of penicillic acid and its interaction with pentobarbital and other compounds.
    Chan PK; Reddy CS; Hayes AW
    Toxicol Appl Pharmacol; 1980 Jan; 52(1):1-9. PubMed ID: 7361304
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of ouabain with pentobarbitone in the mouse.
    Doggett NS
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):56-61. PubMed ID: 4746631
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhalation, parenteral and oral LD50 values of delta 9-tetrahydrocannabinol in Fischer rats.
    Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1974 Apr; 28(1):18-27. PubMed ID: 4852457
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat.
    Pryor GT; Husain S; Mitoma C
    Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of hyperbaric conditions on the responses of animals to central nervous system stimulants and depressants.
    Hart JL
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):260-9. PubMed ID: 4827413
    [No Abstract]   [Full Text] [Related]  

  • 35. Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.
    Gill EW; Jones G
    Biochem Pharmacol; 1972 Aug; 21(16):2237-48. PubMed ID: 4674983
    [No Abstract]   [Full Text] [Related]  

  • 36. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of orally administered delta-9-tetrahydrocannabinol in man.
    Hosko MJ; Kochar MS; Wang RI
    Clin Pharmacol Ther; 1973; 14(3):344-52. PubMed ID: 4698562
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of rubratoxin B and pentobarbital in mice.
    Hayes AW; Ho IK
    J Environ Pathol Toxicol; 1978; 1(4):491-500. PubMed ID: 581497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of conditions influencing endogenous prostaglandins on the activity of delta'-tetrahydrocannabinol in mice.
    Fairbairn JW; Pickens JT
    Br J Pharmacol; 1980 Jul; 69(3):491-3. PubMed ID: 6249435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory effects of delta-9-tetrahydrocannabinol.
    Bellville JW; Swanson GD; Aqleh KA
    Clin Pharmacol Ther; 1975 May; 17(5):541-8. PubMed ID: 1126111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.